Novotech News

  1. Driving Progress Towards Gender Equality And Inclusion 11/6/2023

    At Novotech, we are dedicated to fostering a diverse, equitable and inclusive workplace where all employees, regardless of gender, feel valued, respected and supported.

  2. Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports On Hemophilia And Primary Biliary Cholangitis 11/6/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape reports on Primary Biliary Cholangitis (PBC) and Hemophilia.

  3. Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director And Dr. David Ng, Global Vice President Of Biometrics And Data 10/13/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announces significant senior executive hires to further expand services for Novotech’s global biotech clients.

  4. Dr. Yooni Kim, Vice President Of Clinical Services At Novotech, Delivers Keynote Address At Veeva Korea Summit 10/12/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today that Dr. Yooni Kim, Vice President of Clinical Services at Novotech, served as a keynote speaker at the Veeva Korea Summit this week in Seoul, Korea.

  5. Novotech Secures Consecutive Frost & Sullivan CRO Company Of The Year Award 10/11/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, has been selected as the CRO Company of the Year 2023 by growth advisory and opportunity analytics firm Frost & Sullivan. Novotech has been a recipient of the Frost & Sullivan Best Practices awards since 2006.

  6. Novotech Appoints Dr. Judith Ng-Cashin As Chief Medical Officer To Drive Global Medical Services 10/5/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today the appointment of Dr. Judith Ng-Cashin as Chief Medical Officer (CMO).

  7. Novotech Awarded Cell & Gene Therapy Cro Excellence 2023 9/24/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best CRO for Cell & Gene Therapy 2023 at the Asia Pacific Cell & Gene Therapy Excellence Awards.

  8. Novotech Publishes Nasopharyngeal Carcinoma Global Clinical Trial Landscape Report 9/6/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial report – “Nasopharyngeal Carcinoma: Global Clinical Trial Landscape”.

  9. Novotech Releases Comprehensive Global Landscape Report On Gallbladder Cancer Clinical Trials 9/4/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial report –“Gallbladder Cancer: Global Clinical Trials Landscape Report”.

  10. Novotech Announced As Finalist For Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023 7/12/2023

    Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities is a finalist in the Asia Pacific Cell & Gene Therapy Awards 2023.